Determination of cilostazol and its metabolites in human urine by high performance liquid chromatography

Journal of Pharmaceutical and Biomedical Analysis

Volumn 24, Issue 3, 2001, Pages 381-389

  Tata, Prasad N V ^a   Fu, Chau Hwei J ^b   Bramer, Steven L ^a  

^a OTSUKA PHARMACEUTICAL DEVELOPMENT AND COMMERCIALIZATION INC   (United States)

^b Kansas City Analytical Services   (United States)

Author keywords

Cilostazol; High performance liquid chromatography (HPLC); Human urine; Metabolites; Organic extraction

Indexed keywords

3,4 DIHYDRO 6 [4 [1 (4 HYDROXYCYCLOHEXYL) 1H TETRAZOL 5 YL]BUTOXY] 2(1H) QUINOLINONE; 6 [4 (1 CYCLOHEXYL 1H TETRAZOL 5 YL)BUTOXY] 3,4 DIHYDRO 4 HYDROXY 2(1H) QUINOLINONE; 6 [4 [1 (4 HYDROXYCYCLOHEXYL) 1H TETRAZOL 5 YL]BUTOXY] 2(1H) QUINOLINONE; ACETONITRILE; AMMONIUM ACETATE; BUFFER; CHLOROFORM; CILOSTAZOL; DEHYDROCILOSTAZOL; DRUG METABOLITE; OPC 13211; OPC 13366; OPC 13369; OPC 1533; OPC 3930; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; CONTROLLED STUDY; DRUG STABILITY; DRUG URINE LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIQUID LIQUID EXTRACTION; PRIORITY JOURNAL; RELIABILITY; URINALYSIS; VALIDATION PROCESS;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTROPHOTOMETRY, ULTRAVIOLET; TETRAZOLES;

EID: 0035154027     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0731-7085(00)00426-X     Document Type: Article

References (4)